Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
Evaluating the prevalence of metabolic dysfunction associated steatotic liver disease (MASLD) during pregnancy and its influence on pregnancy outcomes and postpartum maternal health
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 29, 2025
A multicenter, open-label, randomized, phase 2 study of venetoclax and azacitidine plus cusatuzumab versus venetoclax and azacitidine alone in newly diagnosed AML patients who are not candidates for intensive therapy
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 23, 2025
Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of CVN424 in Parkinson's Disease Patients with Motor Complications
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 23, 2025
Serranator OCT: Understanding the Mechanism of Action of Serration Angioplasty by Serranator Versus Conventional Balloon Angioplasty for below-the Knee (BTK) Artery Disease Using Optical Coherence Tomography (OCT)
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 31, 2025
Boomerang-Pivotal Multicenter Trial of the Boomerang Catheter for Percutaneous Deep Vein Arterialization (pDVA)
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 31, 2025
Esprit BTK Post-Approval Study (PAS)
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 31, 2025
Elegance: Drug-Eluting Registry-Real-World Treatment of Lesions in the Peripheral Vasculature
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 31, 2025
A Phase 2 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Patients with Stage 4 Non-Small Cell Lung Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 26, 2025
A Randomized, Open-label, Multicentric, Two-arm Pivotal Trial of SonoCloud-9 Combined With Carboplatin (CBDCA) vs Standard of Care Lomustine (CCNU) or Temozolomide (TMZ) in Patients Undergoing Planned Resection for First Recurrence Glioblastoma
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 27, 2025
Efficacy of Luspatercept In Clonal Cytopenias of Uncertain Significance
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 27, 2025